These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 33491327)
41. Identifying the pathophysiological traits of obstructive sleep apnea during dexmedetomidine sedation. Li C; Ma R; Wu X; Wang D; Chen L; Huang Z; Ji D; Wen W; Wu Y J Sleep Res; 2024 Aug; 33(4):e14079. PubMed ID: 37876325 [TBL] [Abstract][Full Text] [Related]
42. Randomised, controlled crossover trial of intermittent and continuous transcutaneous electrical stimulation of the genioglossus muscle for obstructive sleep apnoea. Wu X; Zhao D; Hu W; Zheng Z; Zha S; Zhang Q; Hu K Thorax; 2023 Jul; 78(7):713-720. PubMed ID: 36690924 [TBL] [Abstract][Full Text] [Related]
43. Regional respiratory movement of the tongue is coordinated during wakefulness and is larger in severe obstructive sleep apnoea. Jugé L; Knapman FL; Burke PGR; Brown E; Bosquillon de Frescheville AF; Gandevia SC; Eckert DJ; Butler JE; Bilston LE J Physiol; 2020 Feb; 598(3):581-597. PubMed ID: 31823371 [TBL] [Abstract][Full Text] [Related]
44. Effect of oxybutynin and reboxetine on obstructive sleep apnea: a randomized, placebo-controlled, double-blind, crossover trial. Berger M; Solelhac G; Marchi NA; Dussez R; Bradley B; Lecciso G; Heiniger G; Bayon V; Van Den Broecke S; Haba-Rubio J; Siclari F; Heinzer R Sleep; 2023 Jul; 46(7):. PubMed ID: 36861433 [TBL] [Abstract][Full Text] [Related]
45. Modification of Endotypic Traits in OSA by the Carbonic Anhydrase Inhibitor Sulthiame. Hoff E; Strassberger C; Zou D; Grote L; Stenlöf K; Hedner J Chest; 2024 Mar; 165(3):704-715. PubMed ID: 37776971 [TBL] [Abstract][Full Text] [Related]
46. Effects of hyperoxia and hypoxia on the physiological traits responsible for obstructive sleep apnoea. Edwards BA; Sands SA; Owens RL; White DP; Genta PR; Butler JP; Malhotra A; Wellman A J Physiol; 2014 Oct; 592(20):4523-35. PubMed ID: 25085887 [TBL] [Abstract][Full Text] [Related]
47. Effects of hypnotics on obstructive sleep apnea endotypes and severity: Novel insights into pathophysiology and treatment. Carter SG; Eckert DJ Sleep Med Rev; 2021 Aug; 58():101492. PubMed ID: 33965721 [TBL] [Abstract][Full Text] [Related]
48. The effect of non-benzodiazepine hypnotics on sleep quality and severity in patients with OSA: a meta-analysis. Zhang XJ; Li QY; Wang Y; Xu HJ; Lin YN Sleep Breath; 2014 Dec; 18(4):781-9. PubMed ID: 24474447 [TBL] [Abstract][Full Text] [Related]
49. Physiology-Based Modeling May Predict Surgical Treatment Outcome for Obstructive Sleep Apnea. Li Y; Ye J; Han D; Cao X; Ding X; Zhang Y; Xu W; Orr J; Jen R; Sands S; Malhotra A; Owens R J Clin Sleep Med; 2017 Sep; 13(9):1029-1037. PubMed ID: 28818154 [TBL] [Abstract][Full Text] [Related]
50. Genioglossus activity available via non-arousal mechanisms vs. that required for opening the airway in obstructive apnea patients. Younes M; Loewen AH; Ostrowski M; Laprairie J; Maturino F; Hanly PJ J Appl Physiol (1985); 2012 Jan; 112(2):249-58. PubMed ID: 21921245 [TBL] [Abstract][Full Text] [Related]
51. Comparing respiratory polygraphy with pulse transit time analysis versus overnight polysomnography in the diagnosis of obstructive sleep apnoea in children. Cheung TW; Lam DS; Chan PC; Yau PS; Yeung KW Sleep Med; 2021 May; 81():457-462. PubMed ID: 33865076 [TBL] [Abstract][Full Text] [Related]
52. Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea. Carley DW; Prasad B; Reid KJ; Malkani R; Attarian H; Abbott SM; Vern B; Xie H; Yuan C; Zee PC Sleep; 2018 Jan; 41(1):. PubMed ID: 29121334 [TBL] [Abstract][Full Text] [Related]
53. Non-continuous positive airway pressure treatment options in obstructive sleep apnoea: A pathophysiological perspective. Bosi M; Incerti Parenti S; Sanna A; Plazzi G; De Vito A; Alessandri-Bonetti G Sleep Med Rev; 2021 Dec; 60():101521. PubMed ID: 34280847 [TBL] [Abstract][Full Text] [Related]
54. Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility. Schweitzer PK; Maynard JP; Wylie PE; Emsellem HA; Sands SA Sleep Breath; 2023 May; 27(2):495-503. PubMed ID: 35551600 [TBL] [Abstract][Full Text] [Related]
55. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial. Chapman JL; Kempler L; Chang CL; Williams SC; Sivam S; Wong KK; Yee BJ; Grunstein RR; Marshall NS Thorax; 2014 Mar; 69(3):274-9. PubMed ID: 24287166 [TBL] [Abstract][Full Text] [Related]
56. Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea. Marshall NS; Yee BJ; Desai AV; Buchanan PR; Wong KK; Crompton R; Melehan KL; Zack N; Rao SG; Gendreau RM; Kranzler J; Grunstein RR Sleep; 2008 Jun; 31(6):824-31. PubMed ID: 18548827 [TBL] [Abstract][Full Text] [Related]
57. Reboxetine and hyoscine butylbromide improve upper airway function during nonrapid eye movement and suppress rapid eye movement sleep in healthy individuals. Lim R; Carberry JC; Wellman A; Grunstein R; Eckert DJ Sleep; 2019 Apr; 42(4):. PubMed ID: 30590857 [TBL] [Abstract][Full Text] [Related]